全文获取类型
收费全文 | 3116篇 |
免费 | 164篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 161篇 |
妇产科学 | 51篇 |
基础医学 | 255篇 |
口腔科学 | 55篇 |
临床医学 | 286篇 |
内科学 | 774篇 |
皮肤病学 | 54篇 |
神经病学 | 143篇 |
特种医学 | 311篇 |
外科学 | 449篇 |
综合类 | 54篇 |
预防医学 | 109篇 |
眼科学 | 126篇 |
药学 | 164篇 |
中国医学 | 2篇 |
肿瘤学 | 288篇 |
出版年
2023年 | 17篇 |
2022年 | 35篇 |
2021年 | 109篇 |
2020年 | 47篇 |
2019年 | 87篇 |
2018年 | 102篇 |
2017年 | 55篇 |
2016年 | 66篇 |
2015年 | 82篇 |
2014年 | 122篇 |
2013年 | 144篇 |
2012年 | 188篇 |
2011年 | 167篇 |
2010年 | 107篇 |
2009年 | 123篇 |
2008年 | 160篇 |
2007年 | 180篇 |
2006年 | 126篇 |
2005年 | 114篇 |
2004年 | 89篇 |
2003年 | 68篇 |
2002年 | 61篇 |
2001年 | 51篇 |
2000年 | 47篇 |
1999年 | 55篇 |
1998年 | 69篇 |
1997年 | 76篇 |
1996年 | 82篇 |
1995年 | 68篇 |
1994年 | 53篇 |
1993年 | 55篇 |
1992年 | 39篇 |
1991年 | 38篇 |
1990年 | 34篇 |
1989年 | 61篇 |
1988年 | 49篇 |
1987年 | 58篇 |
1986年 | 23篇 |
1985年 | 38篇 |
1984年 | 21篇 |
1983年 | 28篇 |
1982年 | 21篇 |
1981年 | 17篇 |
1980年 | 20篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1972年 | 6篇 |
1970年 | 7篇 |
排序方式: 共有3347条查询结果,搜索用时 15 毫秒
51.
52.
53.
Sonal A. Parikh B.S. Scott A. Davis M.A. Daniel P. Krowchuk M.D. Steven R. Feldman M.D. Ph.D. 《Pediatric dermatology》2014,31(5):551-555
Acne is occurring more frequently in younger age groups, but most available treatments are considered off‐label in young children. As the epidemiology of acne has changed to include younger children over the past 20 years, neither regulators, pharmaceutical companies, nor clinicians have understood the need or value of obtaining regulatory sanctions for problems physicians have managed using clinical judgment. The objective of this study was to analyze the frequency of off‐label acne treatment according to age and other demographic factors. We searched the National Ambulatory Medical Care Survey from 1993 to 2010 for visits in children younger than 12 years of age for the diagnosis of International Classification of Diseases, Ninth Revision, code 706.1. We tabulated leading acne treatments and assessed factors associated with off‐label prescribing. Off‐label but appropriate acne treatments were used in 29% of acne visits for children younger than 12 years of age. Dermatologists were more likely than pediatricians to prescribe off‐label treatment (p < 0.001). The most frequently used off‐label treatments were topical retinoids, followed by oral antibiotics. There was no significant trend in the rate of off‐label prescribing over time (p = 0.40). Off‐label treatment is well within the standard of care for young children with acne. More data on the use of topical retinoids in young children will improve our understanding of their use, which may help optimize treatment outcomes for children with acne. 相似文献
54.
Martial L. Ndeffo Mbah Sunil Parikh Alison P. Galvani 《The American journal of tropical medicine and hygiene》2015,92(3):555-560
Artemisinin-based combination therapies (ACTs) are currently considered the first-line treatments for uncomplicated Plasmodium falciparum malaria. Among these, artemether-lumefantrine (AL) has been the most widely prescribed ACT in sub-Saharan Africa. Recent clinical trials conducted in sub-Saharan Africa have shown that dihydroartemisinin-piperaquine (DP), a most recent ACT, may have a longer post-treatment prophylactic period and post-treatment infection period (duration of gametocyte carriage) than AL. Using epidemiological and clinical data on the efficacy of AL and DP, we developed and parameterized a mathematical transmission model that we used to compare the population-level impact of AL and DP for reducing P. falciparum malaria transmission in sub-Saharan Africa. Our results showed that DP is likely to more effectively reduce malaria incidence of clinical episodes than AL. However in low P. falciparum transmission areas, DP and AL are likely to be equally effective in reducing malaria prevalence. The predictions of our model were shown to be robust to the empirical uncertainty summarizing the epidemiological parameters. DP should be considered as a replacement for AL as first-line treatment of uncomplicated malaria in highly endemic P. falciparum communities. To optimize the effectiveness of ACTs, it is necessary to tailor treatment policies to the transmission intensity in different settings. 相似文献
55.
56.
57.
58.
Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine 总被引:2,自引:0,他引:2
Epinephrine causes platelet aggregation and secretion by interacting with alpha 2-adrenergic receptors on the platelet surface. Platelet aggregation requires the binding of fibrinogen to a specific receptor on the membrane glycoprotein IIb-IIIa complex. Although the IIb-IIIa complex is identifiable on the surface of resting platelets, the fibrinogen receptor is expressed only after platelet activation. The current studies were designed to examine the effect of occupancy of platelet alpha 2-adrenergic receptors by epinephrine on the expression of fibrinogen receptors and on the aggregation of platelets. The ability of epinephrine to induce the expression of fibrinogen receptors was studied under two different conditions: acute stimulation (less than 1 min) and prolonged stimulation (50 to 90 min), the latter of which is associated with a reduction or "desensitization" of the platelet aggregation response. Expression of the fibrinogen receptor was monitored with 125I-fibrinogen as well as with 125I-PAC-1 (PAC-1), a monoclonal antibody that binds to the glycoprotein IIb-IIIa complex only after platelets are activated. Epinephrine caused an immediate increase in PAC-1 and fibrinogen binding that was dependent on occupancy of the alpha 2-receptor by epinephrine and on the presence of extracellular free Ca (KCa = 30 mumol/L). By itself, 1 mmol/L Mg was unable to support induction of the fibrinogen receptor by epinephrine. However, it did decrease the Ca requirement by about two orders of magnitude. Prolonged stimulation of unstirred platelets by epinephrine led to a 70% decrease in the aggregation response when the platelets were subsequently stirred. Despite their decreased aggregation response, desensitized platelets bound PAC-1 and fibrinogen normally, indicating that the loss of aggregation was not due simply to a decrease in fibrinogen receptor expression. Although desensitization was not affected by pretreatment of the platelets with aspirin, it was partially prevented when extracellular Ca was chelated by EDTA during the long incubation with epinephrine. These studies demonstrate that once platelet alpha 2-adrenergic receptors are occupied by epinephrine, extracellular Ca is involved in initiating the aggregation response by supporting the induction of the fibrinogen receptor and the binding of fibrinogen. Furthermore. Ca-dependent reactions subsequent to fibrinogen binding may be necessary for maximal platelet aggregation and are impaired when platelets become desensitized to epinephrine. 相似文献
59.
Jonathan G. Amatruda MD Ronit Katz DPhil Carmen A. Peralta MD MAS Michelle M. Estrella MD MHS Harini Sarathy MBBS MHS Linda F. Fried MD MPH Anne B. Newman MD MPH Chirag R. Parikh MBBS PhD Joachim H. Ix MD MAS Mark J. Sarnak MD MS Michael G. Shlipak MD MPH for the Health ABC Study 《Journal of the American Geriatrics Society》2021,69(3):726-734
60.
Raad Mohamad Gorgis Sarah Abshire Chelsea Yost Monica Dabbagh Mohammed F Chehab Omar Aurora Lindsey Patel Sati Nona Paul Yan Jerry Singh Gurjit Syrjamaki John Kaatz Scott Parikh Sachin 《Journal of thrombosis and thrombolysis》2022,53(3):567-575
Journal of Thrombosis and Thrombolysis - Although certain risk factors have been associated with morbidity and mortality, validated emergency department (ED) derived risk prediction models specific... 相似文献